The Law Offices of Timothy L. Miles

Unity Software Inc. Class Action Lawsuit https://www.youtube.com/watch?v=bBuL5T83M3M Unity Software Inc. Class Action Lawsuit The Outset Medical class action lawsuit seeks to represent purchasers or acquirers of Outset Medical, Inc. (NASDAQ: OM) common stock between September 15, 2020 and June 13, 2022, inclusive (the “Class Period”). The Outset Medical class action lawsuit – captioned Plymouth County Retirement Association v. Outset Medical, Inc., No. 22-cv-04016 (N.D. Cal.) – charges Outset Medical and certain of its top executive officers with violations of the Securities Exchange Act of 1934 and is brought on behalf of investors who purchased Outset Medical stock duringn the Class Period. ​ If you suffered losses in Outset Medical stock and wish to serve as lead plaintiff of the Outset Medical class action lawsuit, please provide your information below. You can also contact Outset Medical Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Outset Medical class action lawsuit must be filed with the court no later than September 6, 2022. If you have questions, please contact ​Outset Medical Stock Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/-software-inc.html @The Shareholders @Investor Trading Academy @Bloomberg Markets and Finance @Yahoo Finance #covid #shareholders #investing #investorsformula #at htps://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ

Outset Medical, Inc. Class Action Lawsuit | Outset Class Action Lawsuit https://www.youtube.com/watch?v=GW0ySn9paTA Outset Medical, Inc. Class Action Lawsuit The Outset Medical class action lawsuit seeks to represent purchasers or acquirers of Outset Medical, Inc. (NASDAQ: OM) common stock between September 15, 2020 and June 13, 2022, inclusive (the “Class Period”). The Outset Medical class action lawsuit – captioned Plymouth County Retirement Association v. Outset Medical, Inc., No. 22-cv-04016 (N.D. Cal.) – charges Outset Medical and certain of its top executive officers with violations of the Securities Exchange Act of 1934 and is brought on behalf of investors who purchased Outset Medical stock duringn the Class Period. ​ If you suffered losses in Outset Medical stock and wish to serve as lead plaintiff of the Outset Medical class action lawsuit, please provide your information below. You can also contact Outset Medical Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Outset Medical class action lawsuit must be filed with the court no later than September 6, 2022. If you have questions, please contact ​Outset Medical Stock Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/outset-medical-inc.html @The Shareholders @Investor Network @Yahoo Finance @Bloomberg Markets and Finance @The Modern Investor #covid #shareholders #investing #investorsformula #nasdaily htps://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/

Missfresh Limited Class Action Lawsuit https://www.youtube.com/watch?v=YwQ0pREScak Missfresh Limited Class Action Lawsuit

Wells Fargo & Company Class Action Lawsuit https://www.youtube.com/watch?v=3VFr_8MrUOI Wells Fargo & Company Class Action Lawsuit

Yext, Inc. Class Action Lawsuit | Yext, Inc. Class Action Lawsuit | Yext Stock Loss Lawyer https://www.youtube.com/watch?v=nOuwXU9lB3c Yext, Inc. Class Action Lawsuit The Yext class action lawsuit seeks to represent purchasers or acquirers of Yext, Inc. (NYSE: YEXT) securities between March 4, 2021 and March 8, 2022, inclusive (the “Class Period”). The Yext class action lawsuit – captioned Menzione v. Yext, Inc., No. 22-cv-05127 (S.D.N.Y.) – charges Yext and certain of its top executive officers with violations of the Securities Exchange Act of 1934. ​​ ​If you suffered losses in Yext stock and wish to serve as lead plaintiff of the Yext class action lawsuit, please provide your information below. You can also contact Yext Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Yext class action lawsuit must be filed with the court no later than August 16, 2022. If you have questions, please contact ​Yext Stock Loss Lawyer Timothy L. Miles today about a Yext lawsuit. https://www.classactionlawyertn.com/yext-inc.html @The Shareholders @Bloomberg Markets and Finance @Yahoo Finance @Investor Network @The Modern Investor @Investment Joy #covid #shareholders #investing #investorsformula #investorsformula #shareholders #nasdaily #yahoofinance #marketplace #newyorkstockexchange htps://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ

17 EDUCATION & TECHNOLOGY CLASS ACTION LAWSUIT https://www.youtube.com/watch?v=4rTHeX38-5w 17 EDUCATION & TECHNOLOGY CLASS ACTION LAWSUIT

TG THERAPEUTICS, INC. CLASS ACTION LAWSUIT https://www.youtube.com/watch?v=SDVQR9FOdEc TG THERAPEUTICS, INC. CLASS ACTION LAWSUIT The TG Therapeutics class action lawsuit seeks to represent purchasers or acquirers of TG Therapeutics, Inc. (NASDAQ: TGTX) securities between January 15, 2020 and May 31, 2022, inclusive (the “Class Period”). The TG Therapeutics class action lawsuit – captioned Shapiro v. TG Therapeutics, Inc., No. 22-cv-06106 (S.D.N.Y.) – charges TG Therapeutics and certain of its top executive officers with violations of the Securities Exchange Act of 1934. ​​ If you suffered losses in TG Therapeutics stock and wish to serve as lead plaintiff of the TG Therapeutics class action lawsuit, please provide your information below. You can also contact TG Therapeutics Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the ​TG Therapeutics class action lawsuit must be filed with the court no later than September 16, 2022. If you suffered losses in TG Therapeutics and have questions, please contact ​TG Therapeutics Stock Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/tg-therapeutics-inc.html @The Shareholders @Bloomberg Markets and Finance @Yahoo Finance @Investor Network @Investment Joy #covid #shareholders #investing #investorsformula #investorsformula #shareholders #nasdaily #yahoofinance #marketplace #newyorkstockexchange htps://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ

TG THERAPEUTICS, INC. CLASS ACTION LAWSUIT https://www.youtube.com/watch?v=1NAuhY8GcYE TG THERAPEUTICS, INC. CLASS ACTION LAWSUIT

Uber Technologies, Inc. Class Action Lawsuit https://www.youtube.com/watch?v=pl5Ag0IpV24 Uber Technologies, Inc. Class Action Lawsuit The Uber class action lawsuit seeks to represent purchasers or acquirers of Uber Technologies, Inc. (NYSE: UBER) common stock between May 31, 2019 and July 8, 2022, inclusive (the “Class Period”). The Uber class action lawsuit – captioned Cao v. Uber Technologies, Inc., No. 22-cv-04688 (N.D. Cal.) – charges Uber and certain of its top executive officers with violations of the Securities Exchange Act of 1934. ​​ If you suffered losses in Uber stock and wish to serve as lead plaintiff of the Uber class action lawsuit, please provide your information below. You can also contact Uber Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the ​Uber class action lawsuit must be filed with the court no later than October 17, 2022. If you suffered losses in Uber stock and have questions, please contact ​Uber Stock Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/uber.html @The Shareholders @Investor Network @The Modern Investor @Bloomberg Markets and Finance @Yahoo Finance #covid #shareholders #investing #investorsformula #at htps://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ

Ampio Pharmaceuticals, Inc. Class Action Lawsuit | Suffered losses in Ampio stock https://www.youtube.com/watch?v=YD_fxR3KOGU Ampio Pharmaceuticals, Inc. Class Action Lawsuit The Ampio class action lawsuit seeks to represent purchasers or acquirers of Ampio Pharmaceuticals, Inc. (NYSEAMERICAN: AMPE) common stock between December 29, 2020 and August 3, 2022, inclusive (the “Class Period”). The Ampio class action lawsuit – captioned Kain v. Ampio Pharmaceuticals, Inc., No. 22-cv-02105 (D. Colo.) – charges Ampio and certain of its top executive officers with violations of the Securities Exchange Act of 1934. ​​ If you suffered losses in Ampio stock and wish to serve as lead plaintiff of the Ampio class action lawsuit, please provide your information below. You can also contact Ampio Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the ​Ampio​ class action lawsuit must be filed with the court no later than October 17, 2022. If you suffered losses in Ampio stock and have questions, please contact Ampio Stock Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/ampio-pharmaceuticals.html https://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ @Prime Investors @Investment Joy @The Shareholders @Bloomberg Markets and Finance @Yahoo Finance #shareholders #investing #investorsformula

Co-Diagnostics Inc. Class Action Lawsuit https://www.youtube.com/watch?v=n5giHO3I-kA Co-Diagnostics Inc. Class Action Lawsuit The Co-Diagnostics class action lawsuit seeks to represent purchasers of Co-Diagnostics, Inc. (NASDAQ: CODX) publicly traded securities between May 12, 2022 and the close of the market on August 11, 2022 (4:00 p.m. ET), inclusive (the “Class Period”). The Co-Diagnostics class action lawsuit – captioned Stadium Capital LLC v. Co-Diagnostics, Inc., No. 22-cv-06978 (S.D.N.Y.) – charges Co-Diagnostics and certain of its top executive officers with violations of the Securities Exchange Act of 1934. ​If you suffered losses in Co-Diagnostics stock and wish to serve as lead plaintiff of the Co-Diagnostics class action lawsuit, please provide your information below. You can also contact Co-Diagnostics Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Co-Diagnostics class action lawsuit must be filed with the court no later than October 17, 2022. If you suffered losses in Co-Diagnostics stock and have questions, please contact Co-Diagnostics Stock Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/co-diagnostics-inc.html #covid #shareholders #investing #investorsformula @Investment Joy @The Shareholders @Bloomberg Markets and Finance @Yahoo Finance https://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ

Coinbase Global, Inc. Class Action Lawsuit https://www.youtube.com/watch?v=4P6M_c_xrDQ Coinbase Global, Inc. Class Action Lawsuit The Coinbase class action lawsuit seeks to represent purchasers or acquirers of Coinbase Global, Inc. (NASDAQ: COIN) securities between April 14, 2021 and July 26, 2022, inclusive (the “Class Period”). The Coinbase class action lawsuit – captioned Patel v. Coinbase Global, Inc., No. 22-cv-04915 (D.N.J.) – charges Coinbase and certain of its top executive officers with violations of the Securities Exchange Act of 1934. ​​ If you suffered losses in Coinbase stock and wish to serve as lead plaintiff of the Coinbase class action lawsuit, please provide your information below. You can also contact Coinbase Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Coinbase class action lawsuit must be filed with the court no later than October 3, 2022. If you suffered losses in Coinbase and have questions, please contact Coinbase Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/coinbase-global.html https://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYmQ @Investor Network @Investment Joy @The Shareholders @Amazing Stock @Bloomberg Markets and Finance @MARKET EXPLORE @Yahoo Finance @Nasdaq @The New York Times @New York Stock Exchange

Kiromic BioPharma Class Action Lawsuit | Suffered Losses in Kiromic BioPharma https://www.youtube.com/watch?v=EVDjl5IGdKY https://www.facebook.com/timmileslaw/, Inc. Class Action Lawsuit The Kiromic BioPharma class action lawsuit seeks to represent purchasers or acquirers of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (a) common stock pursuant to the registration statement filed and a final prospectus (together, the “Offering Documents”) issued in connection with Kiromic BioPharma’s public offering that closed on July 2, 2021 (the “Offering”); and/or (b) common stock between June 25, 2021 and August 13, 2021, inclusive (the “Class Period”). The Kiromic BioPharma class action lawsuit – captioned Karp v. Kiromic BioPharma, Inc., No. 22-cv-06690 (S.D.N.Y.) – charges Kiromic BioPharma, certain of its top executive officers and directors, as well as the successor to the Offering’s underwriter with violations of the Securities Act of 1933 and/or Securities Exchange Act of 1934. ​​ If you suffered losses in Kiromic BioPharma stock and wish to serve as lead plaintiff of the Kiromic BioPharma class action lawsuit, please provide your information below. You can also contact Kiromic BioPharma Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at tmiles@timmileslaw.com. Lead plaintiff motions for the Kiromic BioPharma class action lawsuit must be filed with the court no later than October 4, 2022. If you suffered losses in Kiromic BioPharma and have questions, please contact Kiromic BioPharma Loss Lawyer Timothy L. Miles today. https://www.classactionlawyertn.com/kiromic-biopharma.html https://www.pinterest.com/tmiles676767/ https://www.facebook.com/timmileslaw/ https://www.linkedin.com/in/timothy-l-miles-79a69a32/ https://www.instagram.com/10k_law/ https://www.youtube.com/channel/UCbEh7RkQ94C6KVlZGubIYm @InvestFuture @Investment Insights #stockholding #shareholders #stoch @Bloomberg Markets and Finance @MARKET EXPLORE @SMART INVESTORS @Investor Network @Amazing Stock

Carvana Co. Class Action Lawsuit https://www.youtube.com/watch?v=CYrEc74nutQ Carvana Co. Class Action Lawsuit

LifeStance Health Group, Inc. Class Action Lawsuit https://www.youtube.com/watch?v=uCcGGz82zi0 LifeStance Health Group, Inc. Class Action Lawsuit

LifeStance Health Group, Inc. Class Action Lawsuit https://www.youtube.com/watch?v=RsxvIFy4j0k LifeStance Health Group, Inc. Class Action Lawsuit